Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · November 06, 2024

Real-World Evaluation of the Effectiveness and Safety of Dupilumab in Patients With Bullous Pemphigoid

The British Journal of Dermatology

 

Additional Info

The British Journal of Dermatology
Real-World Evaluation of the Effectiveness and Safety of Dupilumab in Bullous Pemphigoid: An Ambispective Multicenter Case Series
Br J Dermatol 2024 Oct 17;[EPub Ahead of Print], N Planella-Fontanillas, X Bosch-Amate, A Jiménez Antón, C Moreno-Vílchez, MG Guerrero, M Del Mar Blanes Martínez, MA Ballester Martínez, P Bassas-Freixas, JL Castaño Fernández, A Estébanez Corrales, R Suarez Fernández, S Santos Alarcón, AB Alonso, M Torrent, A Ballano Ruiz, C Collantes Rodríguez, A España, E Fonseca Capdevila, IG Faure, CP Hernández Fernández, FJ Melgosa Ramos, J Spertino, V Zaragoza Ninet, L Armillas, I Bielsa, C Carrera, ME Rafat, J Fulgencio Barbarin, J Fernandez Vela, M Lova Navarro, CM Callizo, S Martín-Sala, R Ojeda, MEP Amer, AS Puigdollers, RM Pujol, S Podlipnik, JM Mascaró, L Curto-Barredo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading